COURELI
Live / Allowed — Approved for publication (as of 03 Oct 2026)
What this means for you
Approved and waiting on proof of use. It will register unless the applicant drops it, and its 15 Oct 2025 filing date already counts against anyone who files later.
Record
- Serial number
- 79437682
- Mark type
- Word mark
- Filed
- 15 Oct 2025
- Attorney of record
- Emily J Barnhart
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for the treatment of diabetes; pharmaceutical preparations for weight reduction and long term weight loss maintenance; pharmaceutical preparations for the treatment of liver diseases; pharmaceutical preparations for the treatment of cardiovascular diseases, chronic kidney disease, heart failure and hypertension; pharmaceutical preparations for the treatment of neurodegenerative disorders and diseases.
Owner
- Novo Nordisk A/S, DK
Prosecution history
- 03 Oct 2026 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 30 Sept 2026 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 30 Sept 2026 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 30 Sept 2026 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 16 Apr 2026 — REFUSAL PROCESSED BY IB
- 01 Apr 2026 — NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
- 01 Apr 2026 — REFUSAL PROCESSED BY MPU
- 04 Mar 2026 — NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
- 03 Mar 2026 — NON-FINAL ACTION WRITTEN
- 03 Mar 2026 — ASSIGNED TO EXAMINER
- 04 Dec 2025 — APPLICATION FILING RECEIPT MAILED
- 04 Dec 2025 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
- 27 Nov 2025 — SN ASSIGNED FOR SECT 66A APPL FROM IB